Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling

Targeting LAG‐3 restores CD8+ T cell effector function through CD94/NKG2‐Qa‐1b signaling

Saved in:

Bibliographic Details
Main Authors:	Zhiqiang Wang, Mingzhu Yin, Ge Lou
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Series:	MedComm – Oncology
Online Access:	https://doi.org/10.1002/mog2.70003
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

Modulation of NKG2D expression in human CD8(+) T cells corresponding with tuberculosis drug cure.
by: Syeda S Hassan, et al.
Published: (2013-01-01)

Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL
by: Jennifer Bolsée, et al.
Published: (2025-05-01)

MEK inhibition prevents human skin graft rejection by promoting CD8+TCF1+ over CD8 effector T cells
by: Christine Chauveau, et al.
Published: (2025-09-01)

IL-12 drives the expression of the inhibitory receptor NKG2A on human tumor-reactive CD8 T cells
by: Olivier Fesneau, et al.
Published: (2024-11-01)

Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control
by: Hyoungjun Ham, et al.
Published: (2025-02-01)

Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions.
by: Yueqin Qiu, et al.
Published: (2012-01-01)

CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01)

Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4+CD25low and CD8+CD25low effector T cells
by: Raju S. Rajmani, et al.
Published: (2025-07-01)

Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia
by: Maryam Rezaeifar, et al.
Published: (2025-05-01)

Enhanced cytotoxicity of aging associated NKG2C + CD8 + T cells in ankylosing spondylitis via HLA-B27
by: Kunhai Tang, et al.
Published: (2025-06-01)

Activated platelets stimulate effector CD8+ T cells to enhance HNSCC immunotherapy efficacy
by: Zhennan Yuan, et al.
Published: (2025-05-01)

Progressive accumulation of circulating CD27−CD28− effector/memory CD8+ T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapy
by: Sung-Woo Lee, et al.
Published: (2025-05-01)

Analysis of Mitochondrial Function in Antigen Specific na ve, Effector and MEmory CD8 + T Cells
by: Jason M. Grayson, et al.
Published: (2001-01-01)

FTO controls CD8+ T cell survival and effector response by modulating m6A methylation of Fas
by: Lina Sun, et al.
Published: (2025-04-01)

Gfi1 controls the formation of effector-like CD8+ T cells during chronic infection and cancer
by: Oluwagbemiga A. Ojo, et al.
Published: (2025-05-01)

MiR‐29a/b Suppresses CD8+ T Cell Effector Function and Intestinal Inflammation
by: Yingying Lin, et al.
Published: (2025-08-01)

Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice
by: Brock Kingstad-Bakke, et al.
Published: (2025-03-01)

Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells.
by: Richard G Carroll, et al.
Published: (2008-09-01)

STAT3 Regulates Proliferation and Survival of CD8+ T Cells: Enhances Effector Responses to HSV-1 Infection, and Inhibits IL-10+ Regulatory CD8+ T Cells in Autoimmune Uveitis
by: Cheng-Rong Yu, et al.
Published: (2013-01-01)

Spatial regulation of CD8+ T cells at the HLA-E-NKG2A axis drives HIV persistence in lymph node B cell follicles
by: Andrea O. Papadopoulos, et al.
Published: (2025-09-01)

CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway
by: Trinidad Hernández-Caselles, et al.
Published: (2019-01-01)

Role of CD4+T, CD8+T Cells, and CD4+T/CD8+T Cell Ratio in Gastric Cancer and Its Clinical Significance
by: Jingqi Han, et al.
Published: (2022-01-01)

The microbial metabolite butyrate enhances the effector and memory functions of murine CD8+ T cells and improves anti-tumor activity
by: Douglas A. Gaskarth, et al.
Published: (2025-06-01)

CD4+T and CD8+T cells profile in lung inflammation and fibrosis: targets and potential therapeutic drugs
by: Xiaobo Sun, et al.
Published: (2025-05-01)

Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells
by: Yan Wu, et al.
Published: (2024-10-01)

Differential Transcript Profiles of MHC Class Ib(Qa-1, Qa-2, and Qa-10) and Aire Genes during the Ontogeny of Thymus and Other Tissues
by: Breno Luiz Melo-Lima, et al.
Published: (2014-01-01)

BioBone – A prospective, blinded, multicenter validation study of the CD8 + terminal differentiated effector memory cells (CD8 + TEMRA cells) as prognostic biomarker for disturbed fracture healing – study design
by: Simon Reinke, et al.
Published: (2025-06-01)

Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
by: Kerry A. Whalen, et al.
Published: (2023-12-01)

NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors
by: Xia Teng, et al.
Published: (2025-04-01)

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses
by: Jason Ho, et al.
Published: (2023-01-01)

Impaired immune reconstitution in HIV infection: the role of CD4+ T-cell-associated NKG2D ligands, CD4+ T-cell subsets imbalance, and immune function deficiency
by: Qianqian Xu, et al.
Published: (2025-02-01)

Prognostic nutrition index reveals LAG3 in cytotoxic CD8+ T cells and MHC class II in gastric cancer cells
by: Chikanori Tsutsumi, et al.
Published: (2025-04-01)

Correction: Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells
Published: (2024-11-01)

4‐1BB and cytokines trigger human NK, γδ T, and CD8+ T cell proliferation and activation, but are not required for their effector functions
by: Laurent Vidard
Published: (2023-01-01)

CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance
by: Carolina Abrate, et al.
Published: (2025-12-01)

Th17 and effector CD8 T cells relate to disease progression in amyotrophic lateral sclerosis: a case control study
by: Tatsuo Itou, et al.
Published: (2024-12-01)

Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8<sup>+</sup> T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model
by: Yasuhiko Teruya, et al.
Published: (2025-06-01)

TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function
by: Ran Wang, et al.
Published: (2025-12-01)

CD80 Expressed by CD8+ T Cells Contributes to PD-L1-Induced Apoptosis of Activated CD8+ T Cells
by: Meagan R. Rollins, et al.
Published: (2017-01-01)